Page last updated: 2024-12-05
o,o-diethyl dithiophosphate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
O,O-diethyl dithiophosphate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9274 |
| CHEMBL ID | 1886492 |
| CHEBI ID | 189749 |
| SCHEMBL ID | 268312 |
| MeSH ID | M0164322 |
Synonyms (78)
| Synonym |
|---|
| nsc171184 |
| o,o-diethyl-s-hydrogen phosphorodithioate |
| o,o-diethyl dithiophosphoric acid |
| o,o-diethyldithiophosphoric acid |
| wln: shps & o2 & o2 |
| diethyl dithiophosphate |
| o,o-diethyl hydrogen phosphorodithioate |
| o,o-diethyl phosphorodithioate |
| nsc-171184 |
| kyselina o,o-diethyldithiofosforecna |
| 298-06-6 |
| diethyl phosphorodithioic acid |
| o,o-diethyl phosphorodithioic acid |
| o,o-diethyl dithiophosphate |
| o,o-diethyldithiophosphate |
| diethyl phosphorodithioate |
| o,o'-diethyl dithiophosphate |
| dithiophosphoric acid,o-diethyl ester |
| o,o-diethylphosphorodithioic acid |
| phosphonodithioic acid,o-diethyl ester |
| o,o'-diethyl hydrogen dithiophosphate |
| phosphorodithioic acid, o,o-diethyl ester |
| o,o-diethyl hydrogen dithiophosphate |
| brn 0507407 |
| o,o-diethyl dithiophosphoric acid ester |
| di-o-ethyl dithiophosphate |
| o,o-diethyl thiolothionophosphate |
| kyselina o,o-diethyldithiofosforecna [czech] |
| phosphordithioic acid, o,o-diethyl ester |
| einecs 206-055-9 |
| hsdb 5558 |
| nsc 171184 |
| dithiophosphoric acid, o,o-diethyl ester |
| o,o'-diethyl dithiophosphate, technical grade, 90% |
| NCGC00163992-01 |
| NCIOPEN2_007003 |
| 52857-42-8 |
| FT-0694951 |
| dithiophosphoric acid o,o'-diethyl ester |
| D1543 |
| diethylphosphorodithioate |
| diethoxy-sulanyl-sulanylidene-lambda5-phosphane |
| CHEBI:189749 |
| tox21_301493 |
| NCGC00255332-01 |
| cas-298-06-6 |
| dtxcid007133 |
| dtxsid6027133 , |
| A820058 |
| phosphorodithioic acid, diethyl ester |
| unii-02c5xr639p |
| ec 206-055-9 |
| 02c5xr639p , |
| 4-01-00-01354 (beilstein handbook reference) |
| FT-0649368 |
| STL373474 |
| AKOS015901212 |
| diethyl ester of phosphorodithioic acid |
| o,o-diethyl phosphorodithioate [hsdb] |
| SCHEMBL268312 |
| BBL027484 |
| dithiophosphoric acid o,o-diethyl ester |
| dithiophosphoric acid-o,o-diethylester |
| o,o-diethyl s-hydrogen phosphorodithioate |
| (eto)2p(s)sh |
| (c2h5o)2pssh |
| diethyldithiophosphoric acid |
| phosphorodithioic acid, o,o'-diethyl ester |
| o,o-diethyl hydrogen dithiophosphate # |
| o,o-diethylphosphorodithioate |
| phosphorothiothionic acid, o,o-diethyl ester |
| CHEMBL1886492 |
| dithiophosphoricacido,o-diethylester |
| diethyl dithiophosphoric acid |
| J-017651 |
| Q309536 |
| diethoxy-sulfanyl-sulfanylidene-lambda5-phosphane |
| CS-0141956 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
| Class | Description |
|---|---|
| organic thiophosphate | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Protein Targets (5)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 33.4202 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 29.4117 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395; AID1347398 |
| AR protein | Homo sapiens (human) | Potency | 51.6260 | 0.0002 | 21.2231 | 8,912.5098 | AID743036 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 0.0224 | 0.0002 | 14.3764 | 60.0339 | AID588532 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 28.7843 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.39) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||